Abstract-Inappropriate activation of the intrarenal renin-angiotensin system induces generation of reactive oxygen species and tubulointerstitial inflammation, which contribute to salt-sensitive hypertension (SSHT). Liver-type fatty acid-binding protein is expressed in proximal tubules in humans, but not in rodents, and may play an endogenous antioxidative role. The objective of the present study was to examine the antioxidative effect of liver-type fatty acid-binding protein on post-angiotensin II SSHT model in transgenic mice with selective overexpression of human liver-type fatty acid-binding protein in the proximal tubules. The transgenic mice showed marked protection against angiotensin II-induced SSHT.Overexpression of tubular liver-type fatty acid-binding protein prevented intrarenal T-cell infiltration and also reduced reactive oxygen species generation, intrarenal renin-angiotensin system activation, and monocyte chemotactic protein-1 expression. We also performed an in vitro study using the murine proximal tubular cell lines with or without recombinant liver-type fatty acid-binding protein and murine proximal tubular cell lines transfected with human liver-type fatty acid-binding protein, and found that gene transfection of liver-type fatty acid-binding protein and, in part, recombinant liver-type fatty acid-binding protein administration had significantly attenuated angiotensin II-induced reactive oxygen species generation and the expression of angiotensinogen and monocyte chemotactic protein-1 in murine proximal tubular cell lines. These findings indicated that liver-type fatty acid-binding protein in the proximal tubules may protect against angiotensin II-induced SSHT by attenuating activation of the intrarenal renin-angiotensin system and reducing oxidative stress and tubulointerstitial inflammation. Present data suggest that liver-type fatty acid-binding protein in the proximal tubules may be a novel therapeutic target for SSHT. 14 The expression of renal hL-FABP is upregulated in the pathological conditions in these mice, with tubulointerstitial inflammation and fibrosis being markedly attenuated compared with wild-type (WT) mice.12,14 However, the pathophysiological significance of tubular hL-FABP in local RAS activation and subsequent SSHT remains to be determined. The present study analyzed AngII-induced SSHT in hL-FABPTg mice and investigated the underlying mechanism in PTCs with or without hL-FABP transfection or treatment of recombinant L-FABP peptides (rhL-FABP).
MethodsA detailed description of all methods is presented in the online-only Data Supplement.
Results
AngII-Induced SSHT Was Prevented in hL-FABPTg MiceAll groups had the same level of systolic blood pressure (SBP; 102-112 mm Hg) at the beginning of the study (Figure 1). AngII infusion in the WT mice induced a progressive increase in SBP (159.1±13.7 and 177.2±10.7 mm Hg at weeks 2 and 4, respectively; P<0.001 versus WT before and AngII hL-FABPTg at week 4; Figure 1). However, AngII infusion in hL-FABPTg mice induced a small incre...